Biography

I am a consultant ophthalmologist at Manchester Royal Eye Hospital with a specialist interest in uveitis and medical retina. I graduated first in my class from the University of Thessaly Medical School, Greece. I subsequently obtained a Doctor of Philosophy studying the role of Th17 cells in transplantation under the supervision of Herman Waldmann and Stephen Cobbold at the University of Oxford. I completed my ophthalmology specialist training in Liverpool, and a fellowship in medical retina and uveitis at Moorfields Eye Hospital, London. Before joining Manchester Royal Eye Hospital in 2022, I was a consultant ophthalmologist at Oxford Eye Hospital. 

I am the lead for adult uveitis research at Manchester Royal Eye Hospital and I have an interest in biomarkers of immunosuppression and immune profiling of patients with uveitis. In addition to my NHS duties, I am an associate editor at BMJ Open Ophthalmology and a review editor at Frontiers in Ophthalmology, and I serve as an examiner for the Royal College of Ophthalmologists.

Conditions managed and treatments undertaken by Mr Agorogiannis:

• Uveitis (anterior, intermediate, posterior, and panuveitis) including complex disease requiring periocular and intravitreal treatment and systemic immunosuppression
• Scleritis (anterior and posterior) including disease requiring long-term immunosuppressive treatment
• ​Neovascular age-related macular degeneration
• ​Diabetic retinopathy, diabetic macular oedema, retinal vein occlusions, and other retinal vascular diseases
• ​Macular oedema (including uveitic and post-operative)
• ​Central serous chorioretinopathy
• ​Intravitreal steroid injections (including Dexamethasone and Fluocinolone steroid implants)
• ​Intravitreal anti-VEGF injections
• Cataract